top of page
Medicines for Shortages

Bridging supply gaps and alleviating market shortages.

Leveraging our expertise and global network, we navigate complex regulatory frameworks, including the TGA S19A Special Access Scheme, to ensure patients receive essential treatments when they need them most.

  • Expertise in navigating the Special Access Scheme

  • Supporting Healthcare Providers

  • Access to TGA S19A-approved medicines

  • Sourcing, procurement, and compliant delivery and distribution

Legal & Trademark Notice
© 2026 Pro Pharmaceuticals Group Pty Ltd. All rights reserved.
Pro PG, CheckMed, and their respective logos are registered trademarks owned worldwide by Pro Pharmaceuticals Group Pty Ltd.
Pro Pharmaceuticals Group operates globally through associated entities, including CTS Pharmaceuticals Pty Ltd (Australia), Jemstar Sp. z o.o. (Poland), and Pro Pharmaceuticals Group NZ Ltd (New Zealand).

International Tax Registrations:
ABN 20 605 457 430 (Australia) | VAT DE401757398 (EU VAT ID) | Steuernummer 15/460/00493 (Germany) | VAT PL5263362401 (Poland) | VAT NL825524295B01 (Netherlands).

bottom of page